Inotuzumab Ozogamicin (BESPONSA) – Uses, Dosage & Brands in UAE

About Inotuzumab Ozogamicin

Class:| Antineoplastic agent; CD22-directed monoclonal antibody-drug conjugate. Use:| Treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Adult dose:| 0.8 mg/m² on Day 1, 8, and 15 of a 21-day cycle for up to 6 cycles. The dose may be adjusted based on response and tolerability. Pediatric dose:| Safety and efficacy in pediatric patients have not been established. Side effects:| Common side effects include thrombocytopenia, neutropenia, anemia,

Drug Class

| Antineoplastic agent; CD22-directed monoclonal antibody-drug conjugate.

Uses & Indications

| Treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Storage Requirements

Not available

Manufacturer & Packaging

Manufacturer: Pfizer Inc., U.S.A

Package Size

1 Vial

Price & Supplier

Price in UAE: AED 65203.50

Dosage Information

Adult Dose

| 0.8 mg/m² on Day 1, 8, and 15 of a 21-day cycle for up to 6 cycles. The dose may be adjusted based on response and tolerability.

Pediatric Dose

| Safety and efficacy in pediatric patients have not been established.

Side Effects

| Common side effects include thrombocytopenia, neutropenia, anemia, leukopenia, infections, infusion-related reactions, and increased liver enzymes.

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

Inotuzumab Ozogamicin – Uses, Dosage, and Brands in UAE